Showing results (151-160 of 349) with videos related to
Sort By:
Pageof 35
Tropical Medicine & International Health : TM & IH|September 18, 2020
Challenges in the last mile of the global guinea worm eradication programGetahun Weldu Lemma, Olaf Müller, Mark Donald Reñosa, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2017
A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody LevelsAne B Fisker, Eric Nebie, Anja Schoeps, et al.Atherosclerosis|February 18, 2018
Serum matrix metalloproteinase-8, tissue inhibitor of metalloproteinase and myeloperoxidase in ischemic strokeFrederick Palm, Pirkko J Pussinen, Anton Safer, et al.Journal of Hypertension|April 27, 2016
Brunei epidemiological stroke study: patterns of hypertension and stroke riskAgong Lupat, Johannes Hengelbrock, Masliza Luissin, et al.European Journal of Epidemiology|February 7, 2013
Stroke seasonality associations with subtype, etiology and laboratory results in the Ludwigshafen Stroke Study (LuSSt)Frederick Palm, Michael Dos Santos, Christian Urbanek, et al.Cancer|May 17, 2024
Social relationships and their impact on health-related quality of life in a long-term breast cancer survivor cohortMatthias Hans Belau, Lisa Jung, Tabea Maurer, et al.Breast (Edinburgh, Scotland)|January 4, 2021
The effect of family history on screening procedures and prognosis in breast cancer patients - Results of a large population-based case-control studyKatharina Seiffert, Kathrin Thoene, Christine Zu Eulenburg, et al.American Journal of Epidemiology|June 25, 2024
The healthy participant effect: insights and results from a population-based case-control study on breast cancerKevin Maldonado-Cañón, Annika Möhl, Nadia Obi, et al.Vaccines|May 28, 2022
Short-Term Drop in Antibody Titer after the Third Dose of SARS-CoV-2 BNT162b2 Vaccine in AdultsJonas Herzberg, Bastian Fischer, Heiko Becher, et al.Frontiers in Immunology|July 18, 2022
Cellular and Humoral Immune Response to a Third Dose of BNT162b2 COVID-19 Vaccine - A Prospective Observational StudyJonas Herzberg, Bastian Fischer, Heiko Becher, et al.Pageof 35